National Cancer Institute - Drug Information

	Quick Links


	Dictionary Funding Opportunities NCI Publications NCI Calendar Español

	NCI Highlights


	October is Breast Cancer Awareness Month NCI Annual Progress Report on Cancer Research 2003 Women, Tobacco and Cancer: Agenda for 21st Century Past Highlights

Specific Drugs

Gleevec (STI571)

Herceptin

Tamoxifen: Questions and Answers

Drug Development and Approval

Understanding the Approval Process for New Cancer Treatments
A look at how the U.S. Food and Drug Administration relies on the results of clinical trials to ensure the safety and effectiveness of new cancer treatments before they go on the market.

Newly Approved Cancer Treatments
Information from the U.S. Food and Drug Administration (FDA) about recently approved cancer treatments.

Approved Oncology Drugs
Information related to approved oncology drugs, oncology drug approval processes, regulatory information and other oncology drug resources.

FDA Home Page

Cancer Liaison Program
Answers questions from the public about drug approval processes, cancer clinical trials, and access to investigational therapies.

Center for Drug Evaluation and Research

Electronic Orange Book of Approved Drug Products

Guidance Documents for Industry
Contains an archive of documents describing FDA policies on specific topics.

Industry Collaboration
Provides information to industry on the process for getting new drugs into clinical trials.

Investigator's Handbook
Provides information to investigators on specific procedures related to clinical trial development.

Questions and Answers About NCI's Natural Products Branch
A fact sheet that describes the functions of this branch, which collects and analyzes specimens of plant, marine, and microbial origin for possible anticancer properties.